Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial. [electronic resource] by
- Yu, Ke-Da
- Wu, Si-Yu
- Liu, Guang-Yu
- Wu, Jiong
- Di, Gen-Hong
- Hu, Zhen
- Hou, Yi-Feng
- Chen, Can-Ming
- Fan, Lei
- Tang, Li-Chen
- Shen, Zhen-Zhou
- Wu, Ke-Jin
- Zhuang, Zhi-Gang
- Zhang, Hong-Wei
- Shao, Zhi-Ming
Producer: 20200324
In:
Cancer vol. 125
Availability: No items available.
|